Open house showcases Oncimmune's breakthrough test
Oncimmune, based in De Soto, has developed a multi-panel blood test, the Early Cancer Detection Test-Lung, or EarlyCDT-Lung, to detect antigens produced by tumors in early-stage lung cancer. The majority of lung cancer cases, approximately 85 percent according to the Lung Cancer Alliance, are detected in late-stage form and have a mere five-year survival expectancy. An open house on Thursday, Nov. 11 allowed the company to showcase the laboratory where tests are performed to the public and receive open acclaim for their work.
Robotic equipment dispenses Oncimmune's testing serum into a divided plate already prepared with a patient ...
Oncimmune laboratory director Tena Tiruneh describes how the Early Cancer Detection Test-Lung measures the presence ...
Marjorie Brown, a former operating room nurse, gets a closer look at a stack of ...
Advertisement
Comments
Use the comment form below to begin a discussion about this content.
Commenting has been disabled for this item.